(Q34184771)

31 July 2017

1 reference

title

Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments (English)

1 reference

obsessive-compulsive disorder

31 July 2017

0 references

0 references

author

Leonardo F. Fontenelle

object named as

Leonardo F Fontenelle

1

0 references

Christos Pantelis

4

object named as

Christos Pantelis

1 reference

31 July 2017

Ben J Harrison

3

0 references

author name string

Sanne Oostermeijer

2

1 reference

PubMed ID

21568361

31 July 2017

Murat Yücel

5

1 reference

31 July 2017

1 May 2011

1 reference

31 July 2017

1 reference

31 July 2017

71

1 reference

31 July 2017

7

1 reference

31 July 2017

827-840

1 reference

https://scigraph.springernature.com/pub.10.2165/11591790-000000000-00000

31 July 2017

0 references

cites work

Motivation on the Mediterranean: reward, compulsions and habit formation

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Tourette's syndrome, trichotillomania, and obsessive-compulsive disorder: how closely are they related?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Compulsivity and obsessionality in opioid addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Substance use disorders in an obsessive compulsive disorder clinical sample

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Impulse control disorders in adults with obsessive compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Impulse control disorders in patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Common biology of craving across legal and illegal drugs - a quantitative meta-analysis of cue-reactivity brain response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Functional anatomy of obsessive-compulsive phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Neural responses of OCD patients towards disorder-relevant, generally disgust-inducing and fear-inducing pictures.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Prefrontal-striatal pathway underlies cognitive regulation of craving

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Frontostriatal activation in patients with obsessive-compulsive disorder before and after cognitive behavioral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Understanding drug addiction: a neuropsychological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

The role of executive control in human drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Gambling urges in pathological gambling: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Alternation learning in pathological gamblers: an fMRI Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Pathological gambling is linked to reduced activation of the mesolimbic reward system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Subjective sensitivity to monetary gradients is associated with frontolimbic activation to reward in cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Successful treatment of chronic resistant alcoholism by deep brain stimulation of nucleus accumbens: first experience with three cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Altered corticostriatal functional connectivity in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Cerebral glucose metabolic rates in obsessive compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Imaging addiction with PET: is insight in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Frontal-striatal abnormalities underlying behaviours in the compulsive-impulsive spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Failure to respond autonomically to anticipated future outcomes following damage to prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Orbitofrontal contributions to human working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Planning and spatial working memory following frontal lobe lesions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Orbitofrontal cortex: A key prefrontal region for encoding information

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Cognitive inflexibility after prefrontal serotonin depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Understanding obsessive-compulsive disorder: focus on decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Do obsessive-compulsive patients and abstinent heroin addicts share a common psychophysiological mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

A neuropsychological comparison of obsessive-compulsive disorder and trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Strategy implementation in obsessive-compulsive disorder and trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Possible role of neuropeptides in obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Serum antibody for somatostatin-14 and prodynorphin 209-240 in patients with obsessive-compulsive disorder, schizophrenia, Alzheimer's disease, multiple sclerosis, and advanced HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Elevated CSF dynorphin A [1-8] in Tourette's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

A family study of obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Familial and sporadic subtypes of early-onset Obsessive-Compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Mu opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Neurocircuitry of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

High impulsivity predicts the switch to compulsive cocaine-taking

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Approach and avoidance learning in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Medication treatment of different types of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

An update on the pharmacological treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Resistant Obsessive Compulsive disorder (ROC): clinical picture, predictive factors and influence of affective temperaments

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Obsessive-compulsive disorder in people that abuse codeine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Naltrexone augmentation in OCD: a double-blind placebo-controlled cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Adderall for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Psychopharmacology of topiramate: from epilepsy to bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Topiramate in the treatment of substance-related disorders: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Is the GABA B heterodimer a good drug target?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Mechanism of action of stimulants in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder

21 January 2018

2 references

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

21 January 2018

12 December 2020

Motor Inhibition and Cognitive Flexibility in Obsessive-Compulsive Disorder and Trichotillomania

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Worsening of obsessive–compulsive symptoms under methadone tapering

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

The Effects of Topiramate Adjunctive Treatment Added to Antidepressants in Patients with Resistant Obsessive-compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591790-000000000-00000

Coexisting obsessive compulsive disorder and alcoholism

21 January 2018

1 reference

12 December 2020

Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders.

1 reference

12 December 2020

Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD

1 reference

12 December 2020

Neuroendocrine and behavioral effects of naloxone in Tourette syndrome

1 reference

12 December 2020

Provocation of obsessive-compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies

1 reference

12 December 2020

Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome

1 reference

12 December 2020

[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment

1 reference

12 December 2020

Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers

1 reference

12 December 2020

Comorbidity in compulsive hoarding: a case report.

1 reference

12 December 2020

Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder

1 reference

12 December 2020

Pilot trial of ondansetron in the treatment of 8 patients with obsessive-compulsive disorder.

1 reference

12 December 2020

Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder.

1 reference

12 December 2020

Behavioral effects of naloxone infusion in obsessive-compulsive disorder

1 reference

12 December 2020

Obsessive-compulsive spectrum disorders

1 reference

12 December 2020

Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder

1 reference

12 December 2020

The impact of comorbidity on the management of pathological gambling.

1 reference

12 December 2020

Consideration of the relevance of ethological animal models for human repetitive behavioral spectrum disorders

1 reference

12 December 2020

Naloxone administration in obsessive-compulsive disorder: report of two cases

1 reference

12 December 2020

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls

1 reference

12 December 2020

A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.

1 reference

12 December 2020

Rapid remission of OCD with tramadol hydrochloride.

1 reference

12 December 2020

Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder

1 reference

12 December 2020

Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case report

1 reference

12 December 2020

Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania.

1 reference

12 December 2020

10.2165/11591790-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

21568361

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

21568361